| Period Ending | Period | Revenue ($m) | Pre-tax ($m) | EPS | Dividend |
|---|---|---|---|---|---|
| 31-Mar-26 | Q1 | 66.43 | 27.30 | 80.00¢ | 14.00¢ |
| Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-21 | 121.33 | 38.00 | 225.90¢ | 5.3 | 0.5 | +11% | 50.00¢ | 4.2% |
| 31-Dec-22 | 142.08 | 39.64 | 219.90¢ | 6.4 | n/a | -3% | 70.00¢ | 5.0% |
| 31-Dec-23 | 146.31 | 7.97 | (43.60)¢ | n/a | n/a | n/a | 56.00¢ | 4.2% |
| 31-Dec-24 | 183.02 | 40.54 | 91.00¢ | 11.3 | n/a | n/a | 56.00¢ | 5.4% |
| 31-Dec-25 | 267.66 | 106.57 | 283.00¢ | 9.4 | 0.0 | +211% | 56.00¢ | 2.1% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-26 | 326.28 | 146.46 | 255.39p | 5.0 | 0.1 | +71% | 41.85p | 0.0% |
| 31-Dec-27 | 314.60 | 125.56 | 227.46p | 5.6 | n/a | -11% | 41.85p | 0.0% |
Copyright © 2026 FactSet Research Systems Inc. All rights reserved.
| 5 Yr High | 5 Yr Low | 5 Yr Avg | Curr / Avg | |
|---|---|---|---|---|
| Latest | 5.33 | 5.33 | 0.47 | 14.57 |
Find out about IFRS and how this affects the financial infomation for all UK companies.
| Currency | UK Pounds |
| Share Price | 1,275.00p |
| Change Today | -35.00p |
| % Change | -2.67 % |
| 52 Week High | 2,900.00 |
| 52 Week Low | 1,250.00 |
| Volume | 2,322 |
| Shares Issued | 19.34m |
| Market Cap | £246.52m |
| RiskGrade | 174 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income |
|
|---|
| Growth |
|
|---|
| Strong Buy | 0 |
| Buy | 2 |
| Neutral | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 2 |

| Latest | Previous | |
|---|---|---|
| 2nd Interim | 1st Interim | |
| Ex-Div | 22-May-26 | 02-Apr-26 |
| Paid | 05-Jun-26 | 17-Apr-26 |
| Amount | 14.00¢ | 14.00¢ |
| Time | Volume / Share Price |
| 15:33 | 154 @ 1,294.00p |
| 15:27 | 6 @ 1,261.00p |
| 15:10 | 12 @ 1,300.00p |
| 15:10 | 1 @ 1,300.00p |
| 15:10 | 3 @ 1,300.00p |
| CEO | John Mark Learmonth |
You are here: research